SII's Covovax becomes the fourth jab to be used for vaccination of 12-17 age group

SII's Covovax becomes the fourth jab to be used for vaccination of 12-17 age group

https://ift.tt/RUO1pEI is the 4th Covid vaccine authorised for administration in 12 years and above after ZyCoV-D, Bharat Biotech's Covaxin, Biological E's Corbevax.

donewssuper.blogspot.com DNA Web Team

Related Posts

0 Response to "SII's Covovax becomes the fourth jab to be used for vaccination of 12-17 age group"

Post a Comment